155 related articles for article (PubMed ID: 30710281)
1. Targeting S100 Calcium-Binding Proteins with Small Molecule Inhibitors.
Wilder PT; Varney KM; Weber DJ
Methods Mol Biol; 2019; 1929():291-310. PubMed ID: 30710281
[TBL] [Abstract][Full Text] [Related]
2. Specificity of Molecular Fragments Binding to S100B versus S100A1 as Identified by NMR and Site Identification by Ligand Competitive Saturation (SILCS).
Young BD; Yu W; RodrÃguez DJV; Varney KM; MacKerell AD; Weber DJ
Molecules; 2021 Jan; 26(2):. PubMed ID: 33450915
[TBL] [Abstract][Full Text] [Related]
3. The Zn
Baudier J; Deloulme JC; Shaw GS
Biol Rev Camb Philos Soc; 2020 Jun; 95(3):738-758. PubMed ID: 32027773
[TBL] [Abstract][Full Text] [Related]
4. X-ray crystal structure of human calcium-bound S100A1.
Melville Z; Aligholizadeh E; McKnight LE; Weber DJ; Pozharski E; Weber DJ
Acta Crystallogr F Struct Biol Commun; 2017 Apr; 73(Pt 4):215-221. PubMed ID: 28368280
[TBL] [Abstract][Full Text] [Related]
5. S100A1 and S100B: Calcium Sensors at the Cross-Roads of Multiple Chondrogenic Pathways.
Diaz-Romero J; Nesic D
J Cell Physiol; 2017 Aug; 232(8):1979-1987. PubMed ID: 27925190
[TBL] [Abstract][Full Text] [Related]
6. S100A1 and S100B are dispensable for endochondral ossification during skeletal development.
Mori Y; Mori D; Chung UI; Tanaka S; Heierhorst J; Buchou T; Baudier J; Kawaguchi H; Saito T
Biomed Res; 2014; 35(4):243-50. PubMed ID: 25152033
[TBL] [Abstract][Full Text] [Related]
7. S100A1 and S100B expression patterns identify differentiation status of human articular chondrocytes.
Diaz-Romero J; Quintin A; Schoenholzer E; Pauli C; Despont A; Zumstein MA; Kohl S; Nesic D
J Cell Physiol; 2014 Aug; 229(8):1106-17. PubMed ID: 24402969
[TBL] [Abstract][Full Text] [Related]
8. Identification of an S100A1/S100B target protein: phosphoglucomutase.
Landar A; Caddell G; Chessher J; Zimmer DB
Cell Calcium; 1996 Sep; 20(3):279-85. PubMed ID: 8894274
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction.
Markowitz J; Chen I; Gitti R; Baldisseri DM; Pan Y; Udan R; Carrier F; MacKerell AD; Weber DJ
J Med Chem; 2004 Oct; 47(21):5085-93. PubMed ID: 15456252
[TBL] [Abstract][Full Text] [Related]
10. Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles.
Arcuri C; Giambanco I; Bianchi R; Donato R
Neuroscience; 2002; 109(2):371-88. PubMed ID: 11801372
[TBL] [Abstract][Full Text] [Related]
11. Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein.
Okada M; Tokumitsu H; Kubota Y; Kobayashi R
Biochem Biophys Res Commun; 2002 Apr; 292(4):1023-30. PubMed ID: 11944917
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of zinc- and calcium-bound rat S100B as determined by nuclear magnetic resonance spectroscopy.
Wilder PT; Varney KM; Weiss MB; Gitti RK; Weber DJ
Biochemistry; 2005 Apr; 44(15):5690-702. PubMed ID: 15823027
[TBL] [Abstract][Full Text] [Related]
13. S100A1 and S100B expression and target proteins in type I diabetes.
Zimmer DB; Chessher J; Wilson GL; Zimmer WE
Endocrinology; 1997 Dec; 138(12):5176-83. PubMed ID: 9389498
[TBL] [Abstract][Full Text] [Related]
14. Annexin VI binds S100A1 and S100B and blocks the ability of S100A1 and S100B to inhibit desmin and GFAP assemblies into intermediate filaments.
Garbuglia M; Verzini M; Donato R
Cell Calcium; 1998 Sep; 24(3):177-91. PubMed ID: 9883272
[TBL] [Abstract][Full Text] [Related]
15. Novel protein-inhibitor interactions in site 3 of Ca(2+)-bound S100B as discovered by X-ray crystallography.
Cavalier MC; Melville Z; Aligholizadeh E; Raman EP; Yu W; Fang L; Alasady M; Pierce AD; Wilder PT; MacKerell AD; Weber DJ
Acta Crystallogr D Struct Biol; 2016 Jun; 72(Pt 6):753-60. PubMed ID: 27303795
[TBL] [Abstract][Full Text] [Related]
16. Identification of small-molecule inhibitors of the human S100B-p53 interaction and evaluation of their activity in human melanoma cells.
Yoshimura C; Miyafusa T; Tsumoto K
Bioorg Med Chem; 2013 Mar; 21(5):1109-15. PubMed ID: 23375094
[TBL] [Abstract][Full Text] [Related]
17. Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallography.
Charpentier TH; Wilder PT; Liriano MA; Varney KM; Zhong S; Coop A; Pozharski E; MacKerell AD; Toth EA; Weber DJ
Biochemistry; 2009 Jul; 48(26):6202-12. PubMed ID: 19469484
[TBL] [Abstract][Full Text] [Related]
18. Covalent small molecule inhibitors of Ca(2+)-bound S100B.
Cavalier MC; Pierce AD; Wilder PT; Alasady MJ; Hartman KG; Neau DB; Foley TL; Jadhav A; Maloney DJ; Simeonov A; Toth EA; Weber DJ
Biochemistry; 2014 Oct; 53(42):6628-40. PubMed ID: 25268459
[TBL] [Abstract][Full Text] [Related]
19. Ions binding to S100 proteins. I. Calcium- and zinc-binding properties of bovine brain S100 alpha alpha, S100a (alpha beta), and S100b (beta beta) protein: Zn2+ regulates Ca2+ binding on S100b protein.
Baudier J; Glasser N; Gerard D
J Biol Chem; 1986 Jun; 261(18):8192-203. PubMed ID: 3722149
[TBL] [Abstract][Full Text] [Related]
20. Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53.
Markowitz J; Rustandi RR; Varney KM; Wilder PT; Udan R; Wu SL; Horrocks WD; Weber DJ
Biochemistry; 2005 May; 44(19):7305-14. PubMed ID: 15882069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
